QQQ   437.14 (+0.43%)
AAPL   180.75 (-0.37%)
MSFT   407.88 (+0.04%)
META   487.80 (+0.78%)
GOOGL   137.06 (+0.50%)
AMZN   174.65 (+0.86%)
TSLA   199.87 (-1.07%)
NVDA   791.14 (+1.87%)
NIO   5.64 (+3.87%)
AMD   186.56 (+5.68%)
BABA   74.20 (-0.52%)
T   17.00 (+0.24%)
F   12.43 (+1.06%)
MU   89.53 (-0.20%)
CGC   3.32 (-1.19%)
GE   156.12 (+0.33%)
DIS   111.32 (+0.47%)
AMC   4.43 (-11.22%)
PFE   26.89 (-0.55%)
PYPL   60.71 (+0.76%)
XOM   104.75 (+0.41%)
QQQ   437.14 (+0.43%)
AAPL   180.75 (-0.37%)
MSFT   407.88 (+0.04%)
META   487.80 (+0.78%)
GOOGL   137.06 (+0.50%)
AMZN   174.65 (+0.86%)
TSLA   199.87 (-1.07%)
NVDA   791.14 (+1.87%)
NIO   5.64 (+3.87%)
AMD   186.56 (+5.68%)
BABA   74.20 (-0.52%)
T   17.00 (+0.24%)
F   12.43 (+1.06%)
MU   89.53 (-0.20%)
CGC   3.32 (-1.19%)
GE   156.12 (+0.33%)
DIS   111.32 (+0.47%)
AMC   4.43 (-11.22%)
PFE   26.89 (-0.55%)
PYPL   60.71 (+0.76%)
XOM   104.75 (+0.41%)
QQQ   437.14 (+0.43%)
AAPL   180.75 (-0.37%)
MSFT   407.88 (+0.04%)
META   487.80 (+0.78%)
GOOGL   137.06 (+0.50%)
AMZN   174.65 (+0.86%)
TSLA   199.87 (-1.07%)
NVDA   791.14 (+1.87%)
NIO   5.64 (+3.87%)
AMD   186.56 (+5.68%)
BABA   74.20 (-0.52%)
T   17.00 (+0.24%)
F   12.43 (+1.06%)
MU   89.53 (-0.20%)
CGC   3.32 (-1.19%)
GE   156.12 (+0.33%)
DIS   111.32 (+0.47%)
AMC   4.43 (-11.22%)
PFE   26.89 (-0.55%)
PYPL   60.71 (+0.76%)
XOM   104.75 (+0.41%)
QQQ   437.14 (+0.43%)
AAPL   180.75 (-0.37%)
MSFT   407.88 (+0.04%)
META   487.80 (+0.78%)
GOOGL   137.06 (+0.50%)
AMZN   174.65 (+0.86%)
TSLA   199.87 (-1.07%)
NVDA   791.14 (+1.87%)
NIO   5.64 (+3.87%)
AMD   186.56 (+5.68%)
BABA   74.20 (-0.52%)
T   17.00 (+0.24%)
F   12.43 (+1.06%)
MU   89.53 (-0.20%)
CGC   3.32 (-1.19%)
GE   156.12 (+0.33%)
DIS   111.32 (+0.47%)
AMC   4.43 (-11.22%)
PFE   26.89 (-0.55%)
PYPL   60.71 (+0.76%)
XOM   104.75 (+0.41%)

Bristol-Myers Squibb (BMY) Earnings Date, Estimates & Call Transcripts

$50.34
-0.58 (-1.14%)
(As of 11:10 AM ET)

Earnings Summary

Upcoming
Earnings Date
Apr. 25Estimated
Actual EPS
(Feb. 2)
$1.70 Beat By $0.15
Consensus EPS
(Feb. 2)
$1.55
Skip Charts & View Estimated and Actual Earnings Data

BMY Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BMY Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Bristol-Myers Squibb Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20244$1.55$2.07$1.74 
Q2 20244$1.78$2.00$1.87 
Q3 20244$1.61$1.91$1.75 
Q4 20244$1.52$1.84$1.73 
FY 202416$6.46$7.82$7.08 
Q1 20252$1.77$1.81$1.79 
Q2 20252$1.76$1.77$1.77 
Q3 20252$1.69$1.72$1.71 
Q4 20252$1.65$1.67$1.66 
FY 20258$6.87$6.97 $6.92

BMY Earnings Date and Information

Bristol-Myers Squibb last issued its quarterly earnings results on February 2nd, 2024. The biopharmaceutical company reported $1.70 earnings per share for the quarter, topping the consensus estimate of $1.55 by $0.15. The firm earned $11.48 billion during the quarter, compared to analysts' expectations of $11.19 billion. Its revenue for the quarter was up .6% on a year-over-year basis. Bristol-Myers Squibb has generated $3.86 earnings per share over the last year ($3.86 diluted earnings per share) and currently has a price-to-earnings ratio of 13.0. Earnings for Bristol-Myers Squibb are expected to grow by 3.93% in the coming year, from $6.61 to $6.87 per share. Bristol-Myers Squibb has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, April 25th, 2024 based off prior year's report dates.

Bristol-Myers Squibb Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
4/25/2024
Estimated)
------- 
2/2/2024Q4 2023$1.55$1.70+$0.15$2.53$11.19 billion$11.48 billion    
10/26/2023Q3 2023$1.76$2.00+$0.24$3.07$10.96 billion$10.97 billion      
7/27/2023Q2 2023$1.99$1.75($0.24)$2.51$11.81 billion$11.23 billion    
4/27/2023Q1 2023$1.98$2.05+$0.07$3.03$11.50 billion$11.34 billion    
2/2/2023Q4 2022$1.71$1.82+$0.11$2.69$11.20 billion$11.41 billion    
10/25/2022Q3 2022$1.83$1.99+$0.16$3.23$11.18 billion$11.22 billion      
7/27/2022Q2 2022$1.79$1.93+$0.14$3.20$11.50 billion$11.89 billion      
4/29/2022Q1 2022$1.92$1.96+$0.04$3.33$11.34 billion$11.65 billion      
2/4/2022Q4 2021$1.83$1.83-$2.59$12.00 billion$11.96 billion    
10/26/2021Q3 2021$1.92$2.00+$0.08$3.31$11.52 billion$11.62 billion    
7/27/2021Q2 2021$1.89$1.93+$0.04$3.39$11.24 billion$11.70 billion      
4/28/2021Q1 2021$1.82$1.74($0.08)$2.59$11.19 billion$11.07 billion    












Bristol-Myers Squibb Earnings - Frequently Asked Questions

When is Bristol-Myers Squibb's earnings date?

Bristol-Myers Squibb has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, April 25th, 2024 based off last year's report dates. Learn more on BMY's earnings history.

Did Bristol-Myers Squibb beat their earnings estimates last quarter?

In the previous quarter, Bristol-Myers Squibb (NYSE:BMY) reported $1.70 earnings per share (EPS) to beat the analysts' consensus estimate of $1.55 by $0.15. Learn more on analysts' earnings estimate vs. BMY's actual earnings.

How can I listen to Bristol-Myers Squibb's earnings conference call?

The conference call for Bristol-Myers Squibb's latest earnings report can be listened to online. Listen to Conference Call

How can I read Bristol-Myers Squibb's conference call transcript?

The conference call transcript for Bristol-Myers Squibb's latest earnings report can be read online. Read Transcript

How much revenue does Bristol-Myers Squibb generate each year?

Bristol-Myers Squibb (NYSE:BMY) has a recorded annual revenue of $45.01 billion.

How much profit does Bristol-Myers Squibb generate each year?

Bristol-Myers Squibb (NYSE:BMY) has a recorded net income of $8.03 billion. BMY has generated $3.86 earnings per share over the last four quarters.

What is Bristol-Myers Squibb's price-to-earnings ratio?

Bristol-Myers Squibb (NYSE:BMY) has a trailing price-to-earnings ratio of 13.04 and a forward price-to-earnings ratio of 7.62. The price/earnings-to-growth ratio is 1.53.

What is Bristol-Myers Squibb's EPS forecast for next year?

Bristol-Myers Squibb's earnings are expected to grow from $6.61 per share to $6.87 per share in the next year, which is a 3.93% increase.


More Earnings Resources from MarketBeat

This page (NYSE:BMY) was last updated on 2/29/2024 by MarketBeat.com Staff